PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsCongenital adrenal hyperplasia
MeSH D000312 - congenital adrenal hyperplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D047808:Adrenogenital syndrome
0 Companies
0 Drugs
Success rate
D000307:Adrenal gland diseases
0 Companies
0 Drugs
Success rate
D043202:Inborn errors steroid metabolism
0 Companies
0 Drugs
Success rate
D030342:Inborn genetic diseases
$
Success rate
D000312: 
Congenital adrenal hyperplasia
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyHydrocortisone Hydrocortisone  1982-01-01   
Abbott BiotherapeuticsHydrocortisone A-hydrocort  1982-01-01   
Able LaboratoriesHydrocortisone Hemsol-hc  1992-06-19   
AkornHydrocortisone, Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone  2012-07-25   
AllerganHydrocortisone Aeroseb-hc  1982-01-01   
Hydrocortisone Penecort  1984-06-06   
Hydrocortisone Acetasol  1982-01-13   
Hydrocortisone Hydrocortisone  1982-01-01   
Hydrocortisone butyrate Hydrocortisone Butyrate  2017-12-08   
Hydrocortisone, Neomycin, Polymyxin b Otocort  1982-01-01   
AlpharmaHydrocortisone Hydrocortisone  1982-06-07   
AltanaHydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Hydrocortisone Hydrocortisone  1982-01-01   
Amring PharmaceuticalsHydrocortisone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Hydrocortisone  2005-10-31   
ANI PharmaceuticalsHydrocortisone Cortenema  1982-01-01   
Hydrocortisone probutate Pandel  1997-02-28   
APP PharmaceuticalsHydrocortisone Hydrocortisone  1984-06-08   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
100%
8/8
Phase 2
47%
8/17
Phase 3
92%
12/13
Approved: 6Overall Success rate: 43%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use